Select Location
What is your delivery location?
We need your delivery location to continue browsing
Select Location
We need your delivery location to continue browsing
Prescription Required
Aprazer Healthcare Pvt Ltd
28 tablet
Daclatasvir
Keep in cold place
Delivering To:
Overview
Dacikast 60mg Tablet is a prescription-based antiviral medicine. It is prescribed in combination with other medicines to treat Chronic Hepatitis C Virus (HCV) infection. The active ingredient in Hepcdac is Daclatasvir. It works by inhibiting a specific protein known as non-structural protein 5A, which helps reduce the concentration of the Hepatitis C virus in the body. It is important to use this medication correctly, as improper use can lead to severe side effects.
Hepatitis C
Dacikast 60mg Tablet may cause some side effects that vary from one patient to another. Most side effects do not require any medical attention and disappear as your body adjusts to the medicine.
Common side effects include:
Nausea
Rash
Headache
Vomiting
Abdominal pain
Fatigue
Diarrhea
Contact your doctor immediately if you experience any severe or unusual side effects.
The doctor will determine the appropriate dosage of Dacikast 60mg Tablet based on the patient's health and medical conditions. It is important to take this medication at the same time each day as prescribed by your doctor to achieve the best results. You can take it orally, either with or without food. If you suspect an overdose, contact your doctor immediately.
Alcohol
unsafe
Avoid the consumption of alcohol while taking Dacikast 60mg Tablet, as alcohol can reduce the effectiveness of the medicine and worsen the symptoms
Pregnancy
consult your doctor
Do not take Dacikast 60mg Tablet without consulting the doctor in case of pregnancy, as it is an unsafe medicine during this period.
Breast Feeding
consult your doctor
Dacikast 60mg Tablet is unsafe to use during breastfeeding as it may cause toxicity to the baby.
Driving
danger
Dacikast 60mg Tablet may cause side effects such as dizziness or lack of concentration, which could affect your ability to drive. So it's better to avoid driving or operating heavy machinery.
Kidney
precaution
Consumption of Dacikast 60mg Tablet should be avoided without informing the doctor if you have any kidney-related issues.
Liver
precaution
Consumption of Dacikast 60mg Tablet should be avoided without informing the doctor if you have any kidney-related issues.
It is advisable not to miss a dose. If you miss a scheduled dose of dacikast 60mg Tablet tablets, contact your doctor immediately.
Dacikast 60 mg Tablet is a prescribed antiviral medication that reduces the amount of Hepatitis C virus in the body.
Some common side effects of Dacikast 60mg Tablet include fatigue, diarrhea, allergic reaction, nausea, shortness of breath, irregular heartbeat, etc.
This medication works by blocking the activity of a special protein, non-structural 5A, and helps to decrease the load of the Hepatitis C virus in the body.
Follow your doctor’s instructions about any restrictions on food and other activities.
Dacikast tablet is available in a strength of 60mg.
At our pharmacy, your health is our top priority. All of our medicines are safe, effective, and approved by leading health authorities. We partner exclusively with reliable and reputable manufacturers, ensuring the highest quality standards in every product we deliver.
Enjoy the convenience of fast home delivery, secure packaging, and affordable prices—plus special discounts on bulk orders. We’re proud to offer international shipping to a wide range of countries across Asia, Europe, Africa, the Americas, and beyond, making trusted healthcare accessible no matter where you are.
Whether you're a patient or a healthcare provider, you can order with confidence and compassion. Our goal is to ensure that quality healthcare reaches everyone, everywhere.
We currently ship to:
Barbados, Haiti, Trinidad and Tobago, Mexico, Bahamas, Ecuador, Peru, Chile, Brazil, Colombia, Philippines, U.K., USA, Kuwait, Saudi Arabia, UAE, Oman, Qatar, Japan, Ireland, Russia, China, France, Australia, Lithuania, Nigeria, Romania, Algeria, Canada, Singapore, Thailand, Hong Kong, Bahrain, Jordan, Indonesia, Hungary, Moldova, Bulgaria, Azerbaijan, Congo, Ethiopia, Lebanon, Morocco, Mozambique, South Korea, Sri Lanka, Belarus, Mongolia, Malaysia, Vietnam, Tunisia, Zambia, and Israel.
Experience the quality everyone’s talking about – order today!
1. Sulkowski, M. S., Gardiner, D. F., Rodriguez-Torres, M., Reddy, K. R., Hassanein, T., Jacobson, I., ... & Grasela, D. M. (2014). Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection. New England Journal of Medicine, 370(3), 211-221.
2. ABOUHUSSEIN, D., TEAIMA, M. H., AL-NUSEIRAT, A. D. I., BADARY, O., ELNABARAWI, M. A., & ABD EL-MONEM, R. E. H. A. B. (2022). FORMULATION AND CHARACTERIZATION OF ODT USING DIFFERENT CO-PROCESS CONTAINING DACLATSVIR: IN VITRO AND IN VIVO PHARMACOKINETICS STUDY ON HEALTHY VOLUNTEERS FOR HEPATITIS C TREATMENT. Int J App Pharm, 14(5), 105-112.
3. Sangani, M., & Patel, N. V. (2022). STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS DETERMINATION OF SOFOSBUVIR AND DACLATASVIR IN TABLET DOSAGE FORM. Indian Drugs, 59(11).
4. Keating, G. M. (2016). Daclatasvir: a review in chronic hepatitis C. Drugs, 76(14), 1381-1391.
Aprazer Healthcare Pvt Ltd
Written By
Venika Choudhary
Medical Content Writer @ Magicine Pharma
I hold an M.Sc. in Microbiology and have a strong academic foundation in microbial sciences and applied biotechnology. I began my career with extensive hands-on research at CSIR laboratories, focusing on fungal enzyme production, studying fungal diversity in various ecosystems, and developing bio-pesticides as sustainable alternatives to chemical pesticides. This work deepened my understanding of fungal biology, bioactive compounds, and their pharmaceutical and agricultural applications. Transitioning from research, I now work as a medical content writer, where I combine my scientific expertise with a passion for clear and reliable healthcare communication. I apply my research background to create patient-friendly, compliant content for pharmaceutical companies and healthcare platforms, ensuring science is both trustworthy and accessible. Specializing in clear, accurate, and engaging content, I help patients make informed decisions and support pharmaceutical companies in delivering trusted information. Whether writing product descriptions, crafting disease awareness articles, or composing drug information leaflets, I consistently meet regulatory standards and address audience needs, making my content an asset for healthcare brands.
Reviewed By
Dr. Aditya Sarin - MBBS, MD, DrNB - Consultant Medical Oncology
Dr. Aditya Sarin, MBBS, MD, DrNB, is a highly qualified medical oncologist with profound research and clinical expertise, currently working at Sir Ganga Ram Hospital, New Delhi. He is also a member of the European Society of Medical Oncology (ESMO), a non-profit European organization dedicated to eradicating cancer by promoting comprehensive cancer care and advancing medical oncology. He has been honored with several awards, including the International Cancer Foundation scholarship (ESMO congress, 2022) and Young Medical Oncologist of the Year (Times of India, 2024). He is well-known for his breakthrough in oncology. Dr. Sarin is passionate about converting complex health information into a concise and clear form that is understandable to everyone, aiming to create awareness and cancer care among people.